Background
The main aim of this study was to investigate the differences in clinicopathological features between HIV-related primary central nervous system lymphoma (PCNSL) and immunocompetent-primary central nervous system lymphoma (IC-PCNSL).
Methods
The study included thirty-seven patients with HIV-related PCNSL and thirty patients with IC-PCNSL. Hematoxylin & eosin (HE) staining, immunohistochemical detection using CD20, Bcl-2, Bcl-6, p53, C-MYC, Ki67, methyltransferase like factor 3 (METTL3) antibodies, and Epstein–Barr encoding region (EBER) in situ hybridization were performed.
Results
All of the patients were classified as the diffuse large B-cell lymphoma (DLBCL) histological type. Patients with HIV-related PCNSL were younger and more likely to be male compared to patients with IC-PCNSL. Elevated lactate dehydrogenase (LDH) and low sugar content in cerebrospinal fluid (CSF) were more common among HIV-related PCNSL. The expression levels of METTL3, Bcl-2 and p53 were significantly higher in HIV-related PCNSL patients than in IC-PCNSL patients. In contrast, HIV-related PCNSL patients exhibited lower levels of Bcl-6 expression and more likely to be positive for EBER, accounting for 81.1% of these patients. Furthermore, we also found that the expression of METTL3 was lower in germinal center B (GCB)-like DLBCL (n = 7) than in activated B-cell (ABC)-like DLBCL (n = 32) in HIV-related PCNSL (p = 0.041); however, in IC-PCNSL patients, the expression of METTL3 was not significantly different between GCB-like DLBCL and ABC-like DLBCL (p = 0.710).
Conclusion
Our study of Chinese patients with HIV-related PCNSL and IC-PCNSL has revealed new findings: although the tumor manifestations are similar in PCNSL patients with and without HIV, HIV-related PCNSL differs from IC-PCNSL in terms of pathological characteristics including METTL3, Bcl-2, p53, Bcl-6, and EBER. We therefore suggest that the pathogenesis of HIV-related PCNSL and IC-PCNSL may be different due to host's immune status.